Literature DB >> 21566925

Expression of protein-kinase-C isozymes in multidrug-resistant murine leukemia p388/adr cells.

S Gupta, C Kim, Y Qin, S Gollapudi.   

Abstract

Because of a suggested role of protein kinase C (PKC) in multidrug resistance (MDR) and recent molecular cloning of PKC isozymes, we compared the expression of Ca++-dependent PKCalpha. beta and gamma, and Ca++-independent PKCdelta, epsilon, and zeta isozymes between drug sensitive murine leukemia P388 and its MDR subline P388/ADR, using qualitative and quantitative polymerase chain reaction (PCR) and Western blot techniques. The expression of PKCalpha and PKCbeta mRNA and their proteins was higher in P388/ADR as compared to P388 cells. In contrast, PKCdelta, epsilon, zeta mRNA were decreased in P388/ADR cells as compared to P388 cells. However, at the protein level the expression of PKCdelta, epsilon, and zeta was also increased in P388/ADR cells as compared to P388 cells, suggesting an increased rate of translation of PKCdelta, epsilon, and zeta isozymes in P388/ADR cells. No PKCgamma isozyme was detected by PCR and Western blot analyses. Confocal microscopic examination revealed a distinct pattern of subcellular distribution of PKCbeta isozymes in P388/ADR when compared with P388 cells. This study demonstrates the presence of altered levels of PKC isozymes in P388/ADR cells that may suggest a role of certain PKC isozymes in MDR.

Entities:  

Year:  1994        PMID: 21566925

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  2 in total

1.  Protein kinases and multidrug resistance.

Authors:  M G Rumsby; L Drew; J R Warr
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

2.  Inhibition of protein kinase C in multidrug-resistant cells by modulators of multidrug resistance.

Authors:  Y P Hu; J Robert
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.